OtariMed*
*OtariMed monitors post-exertional malaise (PEM) and Cancer Related Fatigue (CRF) to set boundaries to safeguard patient autonomy using AI.
Patient needs not met
Up to 40% of patients receiving medical treatment including chemotherapy (ChT), radiotherapy (RT), hormonal therapy and/or immunotherapy report Cancer Related Fatigue (CRF), while post-exertional malaise (PEM) strikes patients who may suffer due to chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) or post covid (long-haul COVID). They have to rely solely on themselves to monitor their resilience, regardless of their condition and medical treatment.
chemotherapy (ChT)
radiotherapy (RT)
chronic fatigue syndrome (CFS)
post covid (long-haul COVID)
Although the causes may differ, from cancer related fatigue to long covid post-exertional malaise, the patients struggle is similar. The OtariMed team picks up the gauntlet providing help coping fatigue through software solutions at the intersection of daily life and science.
Under construction
Learn more
Nobis quaestio ei pro. Ei natum alienum incorrupte sed, pro te evertitur adversarium, sea an enim indoctum ad nulla eirmod.
Picking up the Gauntlet
Causes may differ and while their aetiology has not always been thoroughly elucidated, Otari's team picks up the gauntlet and sets for it's mission to safeguard patient vulnerability and focus on preserving early patient resilience allowing them to participate in society on their own terms.
Smart technology
Large language models
Human behaviour
Safeguarding patients
Daily schedule
Location based
